We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Pulse Hemoglobin and Pleth Variability Index (Pleth)

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01602978
First Posted: May 21, 2012
Last Update Posted: August 23, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Masimo Labs
Information provided by (Responsible Party):
Davinder Ramsingh, MD, Loma Linda University
March 1, 2012
May 21, 2012
August 23, 2017
February 2010
December 2017   (Final data collection date for primary outcome measure)
The difference between hemoglobin values from the two monitors. [ Time Frame: Pulse hemoglobin will be monitored during the surgery from the first arterial blood gas drawn to the last ABG drawn. ]
The primary outcome measure is the difference between hemoglobin values from the pulse oximetry device and from the arterial blood gas co-oximeter.
Same as current
Complete list of historical versions of study NCT01602978 on ClinicalTrials.gov Archive Site
Difference between measures compared to patient characteristics [ Time Frame: Start of surgery to end of surgery ]
Secondary outcome measures are the size of difference between measures compared to patient characteristics.
Same as current
Not Provided
Not Provided
 
Comparison of Pulse Hemoglobin and Pleth Variability Index
Comparison of Pulse Hemoglobin and Pleth Variability Index to Standard Methods of Guiding Intraoperative Fluid and Transfusion Management During Major Surgical Procedures.
The purpose of this study is to investigate whether a validated sensor that is able to measure how much oxygen-carrying molecules called hemoglobin using pulse hemoglobin and Pleth Variability Index (PVI)] are in your blood during surgery can help your doctors manage how much fluid and possibly blood you need to get during your surgery. The hope of the study is that the device may provide an early indication you are having bleeding and this may mean you need to be treated with a transfusion. Our current method of checking this is by getting a blood sample for analysis. The investigators hope is that this device may be able to alert the clinician of the need for blood or fluids without a blood draw being needed.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
The study population will be adults more than 18 years old that are scheduled for a major surgical procedure.
  • Anemia
  • Fluid Management
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
240
December 2017
December 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects must be >18 years old;
  • must be having a major surgical procedure;
  • The pre-operative estimation of blood loss must be at least 15% of the total blood volume

Exclusion Criteria:

  • Does subject have hemoglobinopathy;
  • cardiac arrhythmias producing irregular rhythms;
  • severe pulmonary disease;
  • procedures where loss of more that 10 to 15% of total blood volume is unlikely;
  • subject refusal
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01602978
5100032
No
Not Provided
Not Provided
Davinder Ramsingh, MD, Loma Linda University
Loma Linda University
Masimo Labs
Principal Investigator: Davinder Ramsingh, MD Loma Linda University
Loma Linda University
August 2017